What Makes a Pharmaceutical Knapp Kit Audit-Ready? Certification, Traceability & Particle Sizing

A pharmaceutical Knapp kit should be more than a collection of vials containing visible defects.

For QA and validation teams, the important question is not simply whether a particle can be seen. The real questions are: What is the defect? How large is it? How was it measured? Which sample contains it? What documentation supports that measurement? And can the history of that sample be reconstructed during an audit?

These questions become especially important when defect kits are used for visual inspector training and qualification, Knapp studies, or the qualification of automatic and semi-automatic visual inspection systems.

USP <1790> describes visual inspection as a probabilistic process and notes that detection probability can change according to factors such as particle size, shape, color and density, dosage form, and container design. This makes scientifically characterized reference samples considerably more useful than unidentified reject units.

An audit-ready Knapp kit therefore combines controlled defect preparation, particle characterization, traceable sample identification, supporting certificates and documented evaluation records.

This guide explains what pharmaceutical companies should look for.

What Does “Audit-Ready” Mean for a Pharmaceutical Knapp Kit?

There is an important distinction between having a defect kit and having a defensible qualification tool.

A basic kit might tell an operator:

Sample 12 contains a glass particle.

An audit-ready system should enable the organization to go further and determine, as applicable:

• what defect or particle is present;
• its documented material/type;
• its measured dimensions;
• how the measurement was performed;
• which uniquely identified container contains the defect;
• what supporting image or measurement record belongs to it;
• what calibrated equipment supported the measurement;
• what evaluation was performed on the prepared unit; and
• what certificate or main report documents the kit configuration.

The goal is traceability and reproducibility, not paperwork for its own sake.

This distinction is especially relevant because visible-particle detection is not perfectly deterministic. A particle being present does not guarantee that every inspector will detect it every time.

That is one reason a properly characterized pharmaceutical Knapp kit can provide a stronger foundation for qualification than a collection of undocumented production rejects.

Why Certification Matters in an Audit-Ready Knapp Kit

Certification gives the user documented information about what has actually been supplied.

For particulate defects, simply labelling a container as glass, fiber, rubber or stainless steel leaves important questions unanswered.

For example:

What size is the particle?

A 100 µm particle and a 1,000 µm particle do not represent the same visual challenge.

How was the size established?

The measurement method and associated equipment matter when particle dimensions are being reported.

Can the measurement be linked to the actual sample?

A certificate becomes far more useful when the documented defect can be traced to the individual numbered container.

A strong certification package therefore connects the physical defect, measurement data and sample identification into one documented system.

Particle Sizing: The Scientific Foundation of a Pharmaceutical Knapp Kit

Particle size is particularly important because visual detectability depends partly on particle characteristics.

USP <1790> recognizes that visual inspection is probabilistic and that detection varies according to characteristics including size, shape, color and density, as well as product and container factors.

That means describing a qualification sample simply as a “visible particle” provides limited information.

What should particle sizing documentation contain?

Depending on the kit specification and defect type, useful records can include:

• particle or fiber type;
• measured dimensions;
• microscopic image;
• sample identification number;
• measurement equipment identification;
• associated calibration documentation; and
• reference to the relevant main report or certificate.

At Confianca Pharmazon, particles and fibers used for Knapp/defect kits can be measured using digital microscopy before seeding. Microscopic images and measured dimensions can then be associated with the relevant sample records.

This provides a documented relationship between the physical defect and the qualification sample.

Why images matter

A measurement value alone provides only part of the evidence.

A microscopic image can help show the morphology of the characterized material and create a visual record associated with the reported dimensions.

For irregular particles and fibers, this can be particularly useful because particulate defects are not always perfectly spherical or uniform.

For more information, see Confianca Pharmazon’s certified particle sizing and regulatory readiness guidance.

Traceability: Can You Follow the Defect From Certificate to Container?

Traceability is one of the clearest differences between an informal defect library and an audit-supportive qualification kit.

Consider a kit containing 50 or 100 samples.

If an auditor, QA reviewer or validation engineer selects one sample and asks:

“What exactly is inside this container?”

your documentation system should make the answer straightforward to establish.

Unique sample identification

Each defect container should have a readable and unique identifier.

That identifier can then correspond to records containing information such as:

Container ID → Defect Type → Particle/Fiber → Size → Image → Evaluation Record

For example:

The values above are illustrative examples of a traceability structure, not actual Confianca certificate data.

The principle is simple:

A user should be able to move from the physical container to its supporting records without ambiguity.

Confianca’s current Knapp Kit approach assigns individual containers a unique identification number corresponding with the main report, helping connect the supplied sample with its documented defect information.

Calibration Documentation Strengthens Measurement Traceability

If a supplier reports a certified particle dimension, QA teams may reasonably want to understand the measurement system behind that value.

That is where calibration documentation becomes relevant.

Depending on the agreed scope, Confianca Pharmazon’s Knapp Kit documentation package can include:

• main certificate for particulate particles and fibers;
• particle/fiber image raw data;
• microscope calibration certificate;
• microscope master calibration documentation;
• applicable ISO 5 work-area documentation; and
• other agreed kit records.

The purpose of these documents is not to make the file thicker.

They help establish a documented chain supporting the measurement and preparation process.

What QA should verify

When reviewing supplier documentation, ask:

1. Which instrument was used to measure the particles?
2. Is the relevant calibration documentation available?
3. Can the measured particle be linked to a microscopic image?
4. Can that image/measurement be linked to the individual kit sample?
5. Is the sample linked to the main kit report?

A clear chain makes later document review substantially easier.

Probability of Detection: Why a Known Particle Is Not Enough

A common mistake is assuming:

Known particle = suitable qualification challenge.

That is not necessarily true.

Visual inspection is probabilistic. Detection can be influenced by:

• particle size;
• particle color and contrast;
• particle shape;
• particle density and movement;
• formulation characteristics;
• container geometry;
• lighting and background;
• inspection technique;
• inspection duration; and
• inspector or machine capability.

This is where Probability of Detection (POD) becomes important.

POD provides information about how consistently a particular defect is detected under defined evaluation conditions.

A unit that is detected nearly every time presents a different challenge from one detected only intermittently.

For qualification applications, understanding that distinction is far more meaningful than knowing merely that a particle was intentionally placed in the sample.

Confianca’s Knapp Kit offering includes POD evaluation documentation depending on the agreed kit scope.

For a deeper explanation of the difference between the physical kit and the statistical study, see the Knapp Study vs. Knapp Kit guide.

7 Essentials of an Audit-Ready Pharmaceutical Knapp Kit

A useful supplier assessment can be built around seven areas:

The most important point is that these components should connect to one another.

Having a calibration certificate in one folder and unidentified particle images in another is not the same as having an integrated traceability system.

What Documentation Should You Request Before Buying a Knapp Kit?

Procurement price should not be the only supplier-selection criterion.

Before issuing a purchase order, QA, QC and validation teams should review the expected documentation package.

Request information on:

• main kit certificate/report;
• defect matrix;
• available particle and fiber materials;
• particle-sizing methodology;
• microscopic images;
• unique container identification;
• applicable microscope calibration documentation;
• applicable controlled-work-area documentation;
• POD evaluation records where included;
• handling and storage requirements;
• replacement policy for damaged units;
• customization options; and
• technical or audit-response support.

A particularly useful procurement step is to request a sample documentation package before final supplier approval.

A brochure tells you what a supplier offers.

A sample certificate package shows you how the supplier documents what it offers.

Confianca Pharmazon’s Knapp Kit Supplier Checklist provides seven supplier-evaluation questions that QA and procurement teams can use during technical assessment.

The Kit Should Match the Product and Inspection Application

There is no universal defect matrix that is ideal for every injectable product.

Qualification samples should be selected with the actual application in mind.

Important variables include:

• vial, cartridge or prefilled syringe;
• clear or colored container;
• liquid or lyophilized formulation;
• formulation appearance;
• manual or automatic inspection;
• relevant defect types;
• particle materials;
• target particle-size ranges; and
• qualification objective.

For example, the visibility of the same particle can change when moving from a clear solution in a transparent vial to a visually complex formulation or presentation.

USP <1790> specifically recognizes that some products and packages can be more difficult to inspect than clear solutions in transparent containers.

This is why a pharmaceutical Knapp kit should ideally be designed around a defined qualification objective, rather than purchased as a generic box of defects.

Maintaining Audit Readiness Throughout the Kit Lifecycle

Audit readiness does not end when the kit arrives.

The user organization also needs suitable controls for handling the kit throughout its usable lifecycle.

1. Control kit identification

Maintain the relationship between physical samples and the original supplier documentation.

Avoid relabelling practices that break traceability.

2. Protect samples from damage

Scratches, closure damage, formulation changes or other deterioration can introduce unintended visual cues.

A sample intended to test particulate detection should not accidentally become identifiable because of unrelated container damage.

3. Follow defined storage conditions

Store the kit according to its supplied handling and storage instructions.

4. Inspect sample condition periodically

Before qualification or requalification activities, verify that samples remain suitable for their intended purpose.

5. Control replacements

If a unit is damaged and replaced, document the change so that the current physical kit continues to match the controlled records.

6. Maintain qualification records separately

The kit’s certificate establishes information about the reference samples.

Your organization’s qualification records establish how those samples were used.

Both are important, but they serve different purposes.

A Certificate Does Not Automatically Make a Kit Audit-Ready

This distinction is important.

A certificate by itself does not automatically establish that a Knapp kit is suitable for every visual inspection programme.

Audit readiness depends on the complete evidence chain:

Defined defect → Characterization → Measurement → Sample identification → Supporting documentation → Controlled use

The kit also needs to be appropriate for the organization’s product, container, inspection method and qualification strategy.

FDA’s draft guidance on inspection of injectable products for visible particulates describes a broader holistic, risk-based approach involving manufacturing controls, visual inspection techniques, particulate identification, investigations and corrective actions.

Therefore, a Knapp kit should be viewed as one controlled component of a larger pharmaceutical visual inspection programme, not a substitute for the programme itself.

How Confianca Pharmazon Supports Audit-Ready Knapp Kits

Confianca Pharmazon provides Visual Inspection Knapp Kits/Defect Kits for applications including manual inspection and automatic visual inspection qualification.

Depending on the agreed project scope, available kit elements include:

• particulate and cosmetic defect samples;
• glass, stainless steel, rubber/elastomeric and other particulate materials;
• colored particles and fibers;
• particle/fiber sizing;
• microscopic images;
• uniquely identified containers;
• main kit documentation;
• relevant microscope calibration documentation;
• applicable ISO 5 work-area documentation;
• POD evaluation records;
• custom preparation according to formulation and container requirements;
• visual inspection training; and
• technical and audit-response support.

Particle offerings currently cover a broad range of sizes, subject to material and preparation feasibility, while kit configurations can be developed for different container and formulation requirements.

Explore the Confianca Visual Inspection Knapp Kit/Defect Kit for current specifications and available customization options.

Frequently Asked Questions

1. What makes a pharmaceutical Knapp kit audit-ready?

An audit-ready pharmaceutical Knapp kit should provide controlled defect samples supported by appropriate identification, characterization, sizing, traceability and documentation. Depending on its intended use, this may include microscopic images, calibration records, POD information and a main kit certificate or report.

2. Why is particle sizing important in a Knapp kit?

Particle size is one factor affecting visual detectability. Documenting particle dimensions allows QA and validation teams to better understand the challenge represented by individual defect samples instead of relying on vague labels such as “small glass particle.”

3. What is traceability in a visual inspection defect kit?

Traceability means being able to connect an individual physical sample to its documented defect information, measurement data, images and relevant supporting records through a unique identifier.

4. Does USP <1790> require a specific Knapp kit?

USP <1790> provides guidance regarding visual inspection of injections and explains important concepts including the probabilistic nature of particle detection. Companies should establish qualification approaches appropriate to their products and processes rather than treating a commercial kit as automatic proof of compliance.

5. What types of particles can be included in a Knapp kit?

Depending on supplier capabilities and the required defect matrix, examples can include glass, stainless steel, rubber or elastomeric particles, colored particles and different fibers. The selection should reflect the qualification objective and relevant manufacturing risks.

6. What is POD in pharmaceutical visual inspection?

Probability of Detection (POD) describes how likely a defined defect is to be detected under specified inspection conditions. It recognizes that visual detection is probabilistic rather than perfectly binary.

7. Can the same Knapp kit be used for manual and automatic visual inspection?

Defect samples may support different visual inspection applications, but the kit configuration and qualification strategy should be appropriate for the particular manual or automated system. Requirements should therefore be defined before kit preparation.

8. What should QA request from a Knapp kit supplier?

QA should review the proposed defect matrix, particle characterization method, sample identification system, certificates, microscopic measurement records, relevant calibration documentation, POD information where applicable, handling requirements and sample documentation package.

Conclusion

An audit-ready pharmaceutical Knapp kit is defined less by the number of defect samples in the box and more by the quality of the evidence behind them.

Certification establishes what was supplied. Particle sizing characterizes the inspection challenge. Unique sample identification creates traceability. Microscopic images and calibration documentation support the measurement record. POD evaluation helps explain how consistently a defect can be detected.

Together, these elements transform a collection of defect samples into a more controlled and defensible qualification resource.

For pharmaceutical manufacturers developing or strengthening a visual inspection programme, Confianca Pharmazon can support customized Knapp/Defect Kits based on the required container, formulation, defect matrix, particulate materials, particle sizes and documentation scope.